High-dose paclitaxel, cyclophosphamide, and cisplatin with autologous hematopoietic progenitor-cell support: a phase I trial. Forty-eight patients with advanced cancer were scheduled to undergo either ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results